COMBINATION CHEMOTHERAPY WITH MITOMYCIN AND VINDESINE IN ADVANCED NON-SMALL CELL LUNG-CANCER - A PILOT-STUDY BY THE LUNG-CANCER WORKING PARTY (BELGIUM)

被引：0
|
作者：
SCULIER, JP
KLASTERSKY, J
DUMONT, JP
VANDERMOTEN, G
ROCMANS, P
LIBERT, P
RAVEZ, P
BECQUART, D
MOMMEN, P
DALESIO, O
机构：
[1] INST JULES BORDET, 1 RUE HEGER BORDET, B-1000 BRUSSELS, BELGIUM
[2] ACAD ZIEKENHUIS MIDDELHEIM, ANTWERPEN, BELGIUM
[3] ACAD ZIEKENHUIS ANTWERPEN, ANTWERPEN, BELGIUM
[4] HOP WARQUIGNIES, BOUSSU, BELGIUM
[5] HOP ERASME, BRUXELLES, BELGIUM
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The combination of mitomycin plus vindesine in advanced non-small cell lung cancer induced an objective response rate of 23% in 43 evaluable patients: 33% in nonpretreated patients (nine response among 27 patients) and 6% in pretreated patients (one response among 16 patients). Toxicity was tolerable. We conclude that the regimen was a moderately active and easy to administer treatment for advanced non-small cell lung cancer.
引用
收藏
页码：773 / 775
页数：3
相关论文
共 50 条
  • [21] COMBINATION CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER WITH DOXORUBICIN AND MITOMYCIN OR CISPLATIN AND ETOPOSIDE
    JOSS, RA
    ALBERTO, P
    OBRECHT, JP
    BARRELET, L
    HOLDENER, EE
    SIEGENTHALER, P
    GOLDHIRSCH, A
    MERMILLOD, B
    CAVALLI, F
    CANCER TREATMENT REPORTS, 1984, 68 (09): : 1079 - 1084
  • [22] CISPLATIN AND CARBOPLATIN IN COMBINATION WITH ETOPOSIDE AS A TREATMENT FOR NON-SMALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EORTC LUNG-CANCER WORKING PARTY
    KLASTERSKY, J
    CANCER TREATMENT REVIEWS, 1988, 15 : 33 - 40
  • [23] COMBINATION CHEMOTHERAPY WITH CISPLATIN, ETOPOSIDE, AND VINDESINE IN NON-SMALL CELL LUNG-CARCINOMA - A CLINICAL-TRIAL OF THE EORTC LUNG-CANCER WORKING PARTY
    KLASTERSKY, J
    SCULIER, JP
    NICAISE, C
    WEERTS, D
    MAIRESSE, M
    LIBERT, P
    ROCMANS, P
    MICHEL, J
    FERREMANS, W
    CANCER TREATMENT REPORTS, 1983, 67 (7-8): : 727 - 730
  • [24] CHEMOTHERAPY OF ADVANCED NON-SMALL CELL LUNG-CANCER - A REVIEW
    TAKASUGI, BJ
    MILLER, TP
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (03) : 339 - 347
  • [25] CHEMOTHERAPY OF NON-SMALL CELL LUNG-CANCER
    WILLIAMS, CJ
    BRITISH JOURNAL OF CANCER, 1989, 60 (01) : 9 - 11
  • [26] CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER
    KOKRON, O
    ONKOLOGIE, 1984, 7 (05): : 285 - 288
  • [27] CHEMOTHERAPY OF NON-SMALL CELL LUNG-CANCER
    MITROU, PS
    KLIPPSTEIN, T
    LAUTENSCHLAGER, G
    ATEMWEGS-UND LUNGENKRANKHEITEN, 1986, 12 (11) : 544 - 549
  • [28] MITOMYCIN-C, VINBLASTINE AND CISPLATIN COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG-CANCER
    NOMURA, F
    SHIMOKATA, K
    SAITO, H
    SAKAI, S
    WATANABE, A
    SAKA, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (04) : 324 - 326
  • [29] VINDESINE AND CISPLATIN COMBINATION CHEMOTHERAPY COMPARED WITH VINDESINE AS A SINGLE AGENT IN THE MANAGEMENT OF NON-SMALL CELL LUNG-CANCER - A RANDOMIZED STUDY
    ELLIOTT, JA
    AHMEDZAI, S
    HOLE, D
    DORWARD, AJ
    STEVENSON, RD
    KAYE, SB
    BANHAM, SW
    STACK, BHR
    CALMAN, KC
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (08): : 1025 - 1032
  • [30] VINDESINE CHEMOTHERAPY IN LUNG-CANCER
    NATALE, RB
    GRALLA, RJ
    WITTES, RE
    GOLBEY, RB
    YOUNG, CW
    CANCER TREATMENT REVIEWS, 1980, 7 : 59 - 63
12345